featured
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932
J. Clin. Oncol 2021 May 01;39(13)1437-1447, AL Angiolillo, RJ Schore, JA Kairalla, M Devidas, KR Rabin, P Zweidler-McKay, MJ Borowitz, B Wood, AJ Carroll, NA Heerema, MV Relling, J Hitzler, AR Lane, KW Maloney, C Wang, M Bassal, WL Carroll, NJ Winick, EA Raetz, ML Loh, SP HungerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.